Clinical Trials

Medistem and Shanghai Jia Fu Medical Apparatus have announced the initiation of critical limb ischemia study by treating first two patients with Endometrial Regenerative Cell (ERC) universal donor stem cells. No treatment-associated adverse events...

ImmunoGen has announced the commencement of the Phase I trial of IMGN853 in ovarian cancer and other solid tumours over-expressing its folate receptor target, including non-small cell lung cancer. The multi-centre, first-in-human trial, will...

Dyax has reported interim analysis results of Phase 2 trial of ecallantide for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema. Based on the data from interim analysis the company decided to discontinue...

Quest PharmaTech has got clearance from FDA to initiate US sites for an ongoing international Phase II clinical trial for oregovomab in advanced ovarian cancer patients. The aim of the trial will be to...

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that Phase III trial of Nexavar  in non-small cell lung cancer patients did not meet primary endpoint of improving overall survival. The Monotherapy admInistration of Sorafenib...

Active Biotech and Ipsen have announced the recruitment of 600 patients in randomized, placebo-controlled Phase III study of tasquinimod in metastatic castrate-resistant prostate cancer patients. The recruitment of half of target patient population triggered...

Peregrine Pharmaceuticals has announced results from its randomized phase II trial, which is designed to determine overall response rate of carboplatin and paclitaxel with or without bavituximab in 86 patients with front-line, Stage IIIb and Stage IV non-small...